HFA News & Notes

HFA Observes National Hepatitis Awareness Month

HFA Observes National Hepatitis Awareness Month FOR IMMEDIATE RELEASE: May 3, 2012 Contact: Richard Pezzillo [...] Read More >>

Community Pharmacists Lose Bid to Immediately Block Express Scripts-Medco Deal

By Rebecca Adams, CQ HealthBeat Associate Editor A federal judge has denied the request of a group of community [...] Read More >>

People with Bleeding Disorders and HCV

Link to Access HCV Therapy Site Friends and supporters, We should all be enormously encouraged by the increasing [...] Read More >>

Contact Info

Hemophilia Federation of America
210 7th St. SE, Suite 200B
Washington D.C., 20003
800.230.9797
202.675.6984
202.675.6983

© 2011 Hemophilia Federation of America · Board of Directors Only · BB Admin Only · Privacy & Legal

NORD's Politico advertisement on ending lifetime and annual caps

The National Organization for Rare Disorders (NORD) ran an advertisement today featuring President Obama’s promise to “prohibit insurers from imposing lifetime limits on benefits and restrict the use of annual limits.” 

HFA has received a number of inquiries concerning the “annual limits” language proposed in the Senate health care reform bill.  Ambiguity in the proposed language has prompted concern with various chronic disorder communities. The legislative language in question reads:

SEC. 2711. NO LIFETIME OR ANNUAL LIMITS.
 ”(a) IN GENERAL.-A group health plan and a health insurance issuer offering group or individual health insurance coverage may not establish-
”(1) lifetime limits on the dollar value of benefits for any participant or beneficiary; or
”(2) unreasonable annual limits (within the meaning of section 223 of the Internal Revenue Code of 1986) on the dollar value of benefits for any participant or beneficiary.

Please continue to call your Senator and ask for immediate removal of lifetime caps!  To contact your Senator, please visit HFA’s Legislative Action Center for contact information.    

To read NORD’s advertisement click here.

Feel free to write your comments and thoughts to this post!